PDS Biotechnology Q3 EPS $(0.19) Beats $(0.22) Estimate
Benzinga Newsdesk 11 months ago
EarningsEarnings BeatsNews
PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) by 13.64 percent. This is a 34.48 percent increase over losses of $(0.29) per share from
PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) by 13.64 percent. This is a 34.48 percent increase over losses of $(0.29) per share from the same period last year.